We are live on ! Find out more
ATNM icon

Actinium Pharmaceuticals
ATNM

43 hedge funds and large institutions have $17.1M invested in Actinium Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 5

140% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 5

25% more capital invested

Capital invested by funds: $13.7M → $17.1M (+$3.47M)

16% more funds holding

Funds holding: 37 → 43 (+6)

1.02% more ownership

Funds ownership: 8.56% → 9.57% (+1%)

7% more call options, than puts

Call options by funds: $4.62M | Put options by funds: $4.32M

Holders
43
Holders Change
+6
Holders Change %
+16.22%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
13
Reduced
5
Closed
5
Calls
$4.62M
Puts
$4.32M
Net Calls
+$302K
Net Calls Change
-$1.82M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$327K
2
ACM
ACT Capital Management
Pennsylvania
+$261K
3
William Blair & Company
William Blair & Company
Illinois
+$215K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$196K
5
SM
Sabby Management
Florida
+$184K

Top Sellers

Rank Fund Capital Flow
1
First Trust Advisors
First Trust Advisors
Illinois
-$406K
2
PA
Pinnacle Associates
New York
-$272K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$153K
4
BCM
Bridgeway Capital Management
Texas
-$139K
5
TRCT
Tower Research Capital (TRC)
New York
-$25.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
26
Osaic Holdings
Arizona
$28K +$4.27K +614 +24%
FDCDDQ
27
Federation des caisses Desjardins du Quebec
Quebec, Canada
$18.6K +$14.6K +2,100 New
EL
28
EMFO LLC
Florida
$15K – – –
RG
29
Retirement Group
California
$15K +$7.3K +1,050 +1,329%
HFM
30
Hartford Financial Management
Connecticut
$5K – – –
TCWM
31
Total Clarity Wealth Management
Illinois
$4K +$3.48K +500 New
BCV
32
Banque Cantonale Vaudoise
Switzerland
$3K +$2.15K +309 New
GFPC
33
Global Financial Private Client
Florida
$2.28K – – –
TRCT
34
Tower Research Capital (TRC)
New York
$2K -$25.1K -3,608 -95%
GWS
35
Glassman Wealth Services
Virginia
$2K +$1.39K +200 New
UBS Group
36
UBS Group
Switzerland
$1K -$18.7K -2,693 -95%
TFO
37
Tarbox Family Office
California
$1K -$1.85K -266 -80%
GI
38
Gradient Investments
Minnesota
$1K – – –
Northwestern Mutual Wealth Management
39
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
TWA
40
TCI Wealth Advisors
Arizona
$1K – – –
TC
41
Truvestments Capital
Florida
$1K – – –
GEA
42
Glen Eagle Advisors
New Jersey
$53 – – –
First Trust Advisors
43
First Trust Advisors
Illinois
– -$406K -51,273 Closed
PA
44
Pinnacle Associates
New York
– -$272K -34,333 Closed
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
– -$153K -22,033 Closed
GAM
46
Gemmer Asset Management
California
– -$3K -400 Closed
1
2

ATNM Hedge Fund Activity: Q3 2021 in Review

43 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Actinium Pharmaceuticals (ATNM) for Q3 2021, worth a combined $17.1M — up 25% from $13.7M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ATNM positions and 5 closed out — a net gain of 7 holders — while 13 added to existing stakes and 5 trimmed.

The largest buyer was Vanguard Group, adding an estimated $327K. The largest seller was First Trust Advisors, exiting entirely with an estimated $406K sold.

  • 43 institutional investors held Actinium Pharmaceuticals (ATNM) as of Q3 2021, up from 37 in Q2 2021.
  • Funds reported $17.1M of Actinium Pharmaceuticals stock for Q3 2021, up 25% quarter-over-quarter.
  • 12 funds opened new Actinium Pharmaceuticals positions in Q3 2021 and 5 closed out, a net change of +7 holders.
  • The largest Actinium Pharmaceuticals buyer in Q3 2021 was Vanguard Group, an estimated $327K added.
  • The largest Actinium Pharmaceuticals seller in Q3 2021 was First Trust Advisors, an estimated $406K sold.

Based on aggregated 13F filings for Q3 2021.